It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Regeneration of human kidneys in animal models would help combat the severe shortage of donors in transplantation therapy. Previously, we demonstrated by interspecific blastocyst complementation between mouse and rats, generation of pluripotent stem cell (PSC)-derived functional pancreas, in apancreatic Pdx1 mutant mice. We, however, were unable to obtain rat PSC-derived kidneys in anephric Sall1 mutant mice, likely due to the poor contribution of rat PSCs to the mouse metanephric mesenchyme, a nephron progenitor. Here, conversely, we show that mouse PSCs can efficiently differentiate into the metanephric mesenchyme in rat, allowing the generation of mouse PSC-derived kidney in anephric Sall1 mutant rat. Glomerular epithelium and renal tubules in the kidneys are entirely composed of mouse PSC-derived cells expressing key functional markers. Importantly, the ureter-bladder junction is normally formed. These data provide proof-of-principle for interspecific blastocyst complementation as a viable approach for kidney generation.
The use of pluripotent-stem cell derived organs for transplantation would be promising, if organs can be grown in a suitable host. Here, the authors use interspecific blastocyst complementation to generate a mouse pluripotent stem cell-derived kidney in anephric Sall1 mutant rats.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 National Institute for Physiological Sciences, Center for Genetic Analysis of Behavior, Okazaki, Japan (GRID:grid.467811.d) (ISNI:0000 0001 2272 1771)
2 National Institute for Physiological Sciences, Center for Genetic Analysis of Behavior, Okazaki, Japan (GRID:grid.467811.d) (ISNI:0000 0001 2272 1771); Jichi Medical University, Center for Molecular Medicine, Shimotsuke, Japan (GRID:grid.410804.9) (ISNI:0000000123090000)
3 The University of Tokyo, Division of Stem Cell Therapy, Institute of Medical Science, Minato-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
4 Shinshu University, Faculty of Textile Science and Technology, Ueda, Japan (GRID:grid.263518.b) (ISNI:0000 0001 1507 4692)
5 National Institute for Physiological Sciences, Center for Genetic Analysis of Behavior, Okazaki, Japan (GRID:grid.467811.d) (ISNI:0000 0001 2272 1771); The Graduate University of Advanced Studies, Okazaki, Japan (GRID:grid.275033.0) (ISNI:0000 0004 1763 208X)
6 The University of Tokyo, Division of Stem Cell Therapy, Institute of Medical Science, Minato-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); Stanford University School of Medicine, Institute for Stem Cell Biology and Regenerative Medicine, Department of Genetics, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956)